Clinical trial
Phase I Clinical Trial in Healthy Female Volunteers of Reactogenicity and Immunogenicity of Nine Vaginal Immunisations With HIV CN54gp140 Glycoprotein
NCT00637962 is registered in ClinicalTrials.gov with St George's, University of London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Clinical Trial in Healthy Female Volunteers of Reactogenicity and Immunogenicity of Nine Vaginal Immunisations With HIV CN54gp140 Glycoprotein
- Lead sponsor
- St George's, University of London
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- September 30, 2007
- Completion date
- January 31, 2009
- Enrollment
- 23 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acquired immune deficiency syndrome, hiv infections